CAR-T cancer link under investigation in new study
NCT ID NCT07378969
First seen Feb 01, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study looks at 30 people who developed a new T-cell cancer after receiving the CAR-T therapy tisagenlecleucel. Researchers will test tumor samples to see if the therapy played a role in causing the cancer. The goal is to better understand the risk, not to offer a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY MALIGNANCIES OF T-CELL ORIGIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGKurume, Fukuoka, 830-8543, Japan
-
Novartis Investigative Site
RECRUITINGOsaka, Osaka, 5418567, Japan
-
Novartis Investigative Site
RECRUITINGBunkyo Ku, Tokyo, 1138677, Japan
Conditions
Explore the condition pages connected to this study.